DOCSLIB.ORG

Perforin/Granzyme-Dependent and Independent Mechanisms Are Both Important for the Development of Graft-Versus-Host Disease After Murine Bone Marrow Transplantation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Perforin/Granzyme-Dependent and Independent Mechanisms Are Both Important for the Development of Graft-Versus-Host Disease After Murine Bone Marrow Transplantation Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. T A Graubert, … , J H Russell, T J Ley J Clin Invest. 1997;100(4):904-911. https://doi.org/10.1172/JCI119606. Research Article Graft-versus-host disease (GvHD) is the major limiting toxicity of allogeneic bone marrow transplantation. T cells are important mediators of GvHD, but the molecular mechanisms that they use to induce GvHD are controversial. Three effector pathways have been described for cytotoxic T lymphocytes: one requires perforin and granzymes, the second Fas (APO-1; CD95) and its ligand. Thirdly, secreted molecules (e.g., TNF-alpha, gamma-IFN) can also mediate cytotoxicity. Together, these mechanisms appear to account for virtually all cytotoxicity induced by activated CTL in standard in vitro lytic assays. Using transplants across histocompatibility barriers, we were able to analyze the contributions of these effector molecules to cell-mediated cytotoxicity in vivo in a GvHD model. We found that Fas ligand is an important independent mediator of class II-restricted acute murine GvHD, while perforin/granzyme-dependent mechanisms have only a minor role in that compartment. In contrast, perforin/ granzyme-dependent mechanisms are required for class I-restricted acute murine GvHD, while Fas ligand is not. The perforin/granzyme pathway may therefore represent a novel target for anti-GvHD drug design. In support of this approach, we provide additional data suggesting that specific perforin/granzyme inhibitors should not adversely affect hematopoietic recovery after transplantation. Find the latest version: https://jci.me/119606/pdf Perforin/granzyme-dependent and Independent Mechanisms are Both Important for the Development of Graft-versus-host Disease After Murine Bone Marrow Transplantation Timothy A. Graubert,* John F. DiPersio,* John H. Russell,‡ and Timothy J. Ley* *Division of Bone Marrow Transplantation and Stem Cell Biology, Department of Internal Medicine and Department of Genetics; and ‡Department of Molecular Biology and Pharmacology, Washington University Medical School, St. Louis, Missouri 63110-1093 Abstract dence that T cells mediate GvHD (1). T cell depletion, how- ever, is associated with an increased risk of graft failure (2) and Graft-versus-host disease (GvHD) is the major limiting tox- relapse of malignancy after transplantation (3). Efforts to ex- icity of allogeneic bone marrow transplantation. T cells are plain the molecular basis of T cell cytotoxicity are motivated important mediators of GvHD, but the molecular mecha- by a desire to develop more precise strategies for manipulating nisms that they use to induce GvHD are controversial. Three donor T cells, while preserving a favorable balance between effector pathways have been described for cytotoxic T lym- their beneficial and harmful effects in the host. phocytes: one requires perforin and granzymes, the second Murine bone marrow transplant models developed in the Fas (APO-1; CD95) and its ligand. Thirdly, secreted mole- past decade have demonstrated that CD4ϩ and CD8ϩ cyto- cules (e.g., TNF-␣, ␥-IFN) can also mediate cytotoxicity. To- toxic T lymphocytes (CTL) can both mediate lethal GvHD (4, gether, these mechanisms appear to account for virtually all 5). These effector populations induce GvHD syndromes with cytotoxicity induced by activated CTL in standard in vitro similar natural histories and dose-response relationships. In lytic assays. Using transplants across histocompatibility bar- vitro experiments, however, suggest that two distinct cytotoxic riers, we were able to analyze the contributions of these ef- mechanisms exist and may be used differently in CD4ϩ and fector molecules to cell-mediated cytotoxicity in vivo in a CD8ϩ CTL. Both pathways culminate in the apoptotic death GvHD model. We found that Fas ligand is an important in- of target cells. dependent mediator of class II–restricted acute murine The first apoptotic mechanism is the granule exocytosis GvHD, while perforin/granzyme-dependent mechanisms have pathway. In this model, the specific recognition and binding of a only a minor role in that compartment. In contrast, perforin/ CTL to a susceptible target cell leads to discharge of the lympho- granzyme-dependent mechanisms are required for class cyte’s secretory granules into the extracellular space. One of I–restricted acute murine GvHD, while Fas ligand is not. the granule components is perforin, which undergoes Caϩϩ- The perforin/granzyme pathway may therefore represent a dependent polymerization on the target cell membrane, creat- novel target for anti-GvHD drug design. In support of this ing a complement-like lesion (6, 7). This membrane damage approach, we provide additional data suggesting that spe- is not sufficient to cause apoptotic death of the cell (8), but cific perforin/granzyme inhibitors should not adversely af- may allow other granule constituents (including the granzymes) fect hematopoietic recovery after transplantation. (J. Clin. to gain access to the target cell cytoplasm. There, the gran- Invest. 1997. 100:904–911.) Key words: graft-versus-host zymes trigger a series of biochemical events that result in apop- disease • hematopoiesis • perforin • granzyme B • Fas tosis (9–13). CTL from mice deficient in perforin have a se- vere defect in their ability to induce apoptosis (14–17). Introduction Granzyme B is required for the early phase of perforin-depen- dent cytotoxicity (18). Bone marrow transplantation across major or minor histocom- The second pathway involves the Fas/Fas ligand interac- patibility barriers carries a significant risk of death from graft- tion. Activated CTL upregulate expression of Fas ligand versus-host disease (GvHD).1 The elimination of GvHD by (FasL), a membrane-bound protein with homology to TNF depleting bone marrow grafts of T cells provided strong evi- (19). Binding of FasL to its receptor (APO-1; CD95), present on the surface of target cells, triggers apoptosis through a Address correspondence to Timothy J. Ley, M.D., Washington Uni- death domain on the cytoplasmic tail of the Fas receptor via a versity Medical School, Division of Bone Marrow Transplantation series of docking proteins. These proteins transmit the death and Stem Cell Biology, Campus Box 8007, 660 South Euclid Avenue, signal through intermediates that include cysteine proteinases St. Louis, MO 63110-1093. Phone: 314-362-8831; FAX: 314-362-9333; of the caspase family (20–24). Mice with a naturally occurring E-mail: [email protected] loss of function mutation of FasL (gld/gld) accumulate double Received for publication 24 February 1997 and accepted in revised negative (CD4ϪCD8Ϫ) T cells in the periphery (25) due to a form 21 May 1997. failure of activation-induced cell death of mature T cells (26, 27). Reduced cytotoxicity of gld/gld effectors has demon- 1. Abbreviations used in this paper: BFU-E, burst-forming unit eryth- strated the importance of a Fas/FasL-dependent mechanism of roid; CFU-GM, colony-forming unit granulocyte macrophage; CTL, cytotoxicity in vitro (28), particularly in CD4ϩ CTL (28–30). cytotoxic T lymphocytes; CFU-S8, day 8 spleen colony-forming unit; FasL, Fas ligand; GvHD, graft-versus-host disease. Allogeneic transplants from mice doubly deficient in per- forin and FasL (31), but not FasL alone, have been shown to J. Clin. Invest. cause less mortality from GvHD. Similarly, the onset of lethal © The American Society for Clinical Investigation, Inc. GvHD is delayed using perforin-deficient effectors, while he- 0021-9738/97/08/0904/08 $2.00 patic and cutaneous pathology is absent after transfer of FasL- Volume 100, Number 4, August 1997, 904–911 deficient effectors in transplants across an MHC-matched allo- http://www.jci.org geneic barrier (32). These studies, however, did not define the 904 Graubert et al. T cell compartments affected by the mutations. We previously (Sigma Chemical Co., St. Louis, MO) and 50 U/ml rhIL-2 for 48 h) reported that granzyme B is an important mediator of cytotox- were used as a source of positive control RNA; T cells acquire a CTL icity in vivo mediated by CD8ϩ, but not CD4ϩ CTL (33). This phenotype under these culture conditions, as characterized by signifi- study was conducted to define further the role of perforin/ cant upregulation of granzymes A and B (40) and perforin (41) ex- granzyme-dependent and independent mechanisms in the de- pression. Negative control samples (no RNA) were processed in par- allel. Specific end-labeled DNA probes (100,000 total cpm) were used velopment of GvHD across class I and class II barriers. We to detect correctly processed human ␤-actin and granzyme B mRNAs found that a perforin/granzyme-independent mechanism (i.e., as previously described (39). The perforin probe was generated by the Fas system) is an important mediator of GvHD across a PCR from genomic K562 (human erythroleukemia cell) DNA. The class II barrier in this model. The perforin/granzyme pathway fragment was end-labeled at a BamH1 site; correctly processed per- does not contribute significantly to class II-restricted GvHD, forin mRNA protects a 413-nucleotide exon 2 probe fragment from but it is essential for class I-restricted GvHD. This observation S1 nuclease digestion. suggests to us that inhibition of the perforin/granzyme path- Acute GvHD model. Lymphocytes were isolated from the me- way may represent a novel target for GvHD therapy. senteric lymph nodes of sex-matched littermate donors after passage Until recently, the expression of perforin and granzyme B through a stainless steel mesh. T cell subsets were then prepared as had not been detected outside the lymphoid compartment (34, previously described (33). In brief, antibody-mediated complement lysis was performed by adsorbing antibodies to B cells (MoAb J11d) 35). Berthou, et al. (36), however, found evidence of perforin and CD4ϩ cells (MoAb RL.172) or CD8ϩ cells (MoAb 3.155) at 4ЊC and granzyme B expression in KG1a (human acute myeloge- for 30 min at a concentration of 107 lymphocytes/ml in RPMI 1640 ϩ nous leukemia) cells and in CD34 peripheral blood cells from (Sigma Chemical Co., St.
Load more

Recommended publications
  • Calreticulin—Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance As a Prognostic Biomarker in Ovarian
    cells Review Calreticulin—Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients Michal Kielbik *, Izabela Szulc-Kielbik and Magdalena Klink Institute of Medical Biology, Polish Academy of Sciences, 106 Lodowa Str., 93-232 Lodz, Poland; [email protected] (I.S.-K.); [email protected] (M.K.) * Correspondence: [email protected]; Tel.: +48-42-27-23-636 Abstract: Immunogenic cell death (ICD) is a type of death, which has the hallmarks of necroptosis and apoptosis, and is best characterized in malignant diseases. Chemotherapeutics, radiotherapy and photodynamic therapy induce intracellular stress response pathways in tumor cells, leading to a secretion of various factors belonging to a family of damage-associated molecular patterns molecules, capable of inducing the adaptive immune response. One of them is calreticulin (CRT), an endoplasmic reticulum-associated chaperone. Its presence on the surface of dying tumor cells serves as an “eat me” signal for antigen presenting cells (APC). Engulfment of tumor cells by APCs results in the presentation of tumor’s antigens to cytotoxic T-cells and production of cytokines/chemokines, which activate immune cells responsible for tumor cells killing. Thus, the development of ICD and the expression of CRT can help standard therapy to eradicate tumor cells. Here, we review the physiological functions of CRT and its involvement in the ICD appearance in malignant dis- ease. Moreover, we also focus on the ability of various anti-cancer drugs to induce expression of surface CRT on ovarian cancer cells. The second aim of this work is to discuss and summarize the prognostic/predictive value of CRT in ovarian cancer patients.
    [Show full text]
  • Apoptosis by Incomplete Infection
    rESEArcH HIGHLIGHtS Apoptosis by incomplete infection Constraining inflammation κ Infection with human immunodeficiency virus (HIV) is The transcription factor NF- B is a critical mediator of Toll-like recep- characterized by progressive apoptosis of CD4+ T cells, and tor (TLR) signaling in response to a range of activators. In Genes & although some of the molecular participants in this process are Development, Barish et al. provide genetic and genomic evidence that known, the precise details remain unclear. Greene and colleagues the transcription factor Bcl-6 broadly antagonizes the TLR–NF-κB in Cell report the unexpected finding that nonproductive infection network. Genome-wide expression analyses and chromatin-immuno- of CD4+ T cells can also result in apoptosis. The authors use a precipitation sequencing (ChIP-Seq) show that Bcl-6 is a basal- and human lymphoid aggregation culture system to recapitulate in lipopolysaccharide (LPS)-induced inhibitor of many inflammatory vitro the events of HIV infection in the lymph node. The addition modules in bone marrow–derived macrophages. Bcl-6 controls one of HIV to this culture system results in the apoptosis of not only third of the LPS-elicited transcriptome, and sites for Bcl-6 and the productively infected but also nonpermissive CD4+ cells. Apoptosis NF-κB subunit p65 are located together in a nucleosomal window of the latter requires fusion with HIV and the initiation but not (200 base pairs) in 25% of the gene network controlled by TLR–NF-κB. completion of viral reverse transcription. The accumulation Stimulation of TLR4 reciprocally diminishes or enhances the binding of of incomplete HIV reverse transcripts results in activation of Bcl-6 and p65 to enhancer regions at target genes encoding key inflam- caspase-1 and caspase-3 and release of the inflammatory cytokine matory molecules, such as IL-1 and various chemokines.
    [Show full text]
  • Mechanism of Mammalian Cell Lysis Mediated by Peptide Defensins
    Mechanism of Mammalian Cell Lysis Mediated by Peptide Defensins Evidence for an Initial Alteration of the Plasma Membrane Alan Lichtenstein Division ofHematology/Oncology, Department ofMedicine, Veterans Administration Wadsworth-UCLA Medical Center, Los Angeles, California 90073 Abstract targets, are three small (mol wt 3,900) cationic peptides termed defensins or human neutrophil peptides 1, 2, and 3 (HNP Defensins induce ion channels in model lipid bilayers and per- 1-3).' The human defensins are secreted by activated PMNs meabilize the membranes of Escherichia coli. We investigated (10) and could, therefore, function as cytotoxins during anti- whether similar membrane-active events occur during defensin- body-dependent cellular cytotoxicity. In addition, a synergistic mediated cytolysis of tumor cells. Although defensin-treated cytotoxic effect occurs when target cells are exposed to a combi- K562 targets did not release chromium-labeled cytoplasmic nation of defensins and toxic oxidants (8). It is, thus, conceiv- components for 5-6 h, they experienced a rapid collapse able that defensins may play a role in tissue injury seen during (within minutes) of the membrane potential, efflux of rubidium, inflammatory or infectious processes. and influx of trypan blue. Defensin treatment also blunted the To investigate the mechanism of defensin-induced injury, subsequent acidification response induced by nigericin, thereby we have utilized continuously cultured tumor cells as model further supporting the notion of enhanced transmembrane ion targets. In previous studies (11, 12), K562 cells exposed to de- flow during exposure. These initial effects on the plasma mem- fensins began to release radiolabeled chromium after a lag pe- brane were not sufficient for subsequent lysis; a second phase of riod of 3-4 h.
    [Show full text]
  • I M M U N O L O G Y Core Notes
    II MM MM UU NN OO LL OO GG YY CCOORREE NNOOTTEESS MEDICAL IMMUNOLOGY 544 FALL 2011 Dr. George A. Gutman SCHOOL OF MEDICINE UNIVERSITY OF CALIFORNIA, IRVINE (Copyright) 2011 Regents of the University of California TABLE OF CONTENTS CHAPTER 1 INTRODUCTION...................................................................................... 3 CHAPTER 2 ANTIGEN/ANTIBODY INTERACTIONS ..............................................9 CHAPTER 3 ANTIBODY STRUCTURE I..................................................................17 CHAPTER 4 ANTIBODY STRUCTURE II.................................................................23 CHAPTER 5 COMPLEMENT...................................................................................... 33 CHAPTER 6 ANTIBODY GENETICS, ISOTYPES, ALLOTYPES, IDIOTYPES.....45 CHAPTER 7 CELLULAR BASIS OF ANTIBODY DIVERSITY: CLONAL SELECTION..................................................................53 CHAPTER 8 GENETIC BASIS OF ANTIBODY DIVERSITY...................................61 CHAPTER 9 IMMUNOGLOBULIN BIOSYNTHESIS ...............................................69 CHAPTER 10 BLOOD GROUPS: ABO AND Rh .........................................................77 CHAPTER 11 CELL-MEDIATED IMMUNITY AND MHC ........................................83 CHAPTER 12 CELL INTERACTIONS IN CELL MEDIATED IMMUNITY ..............91 CHAPTER 13 T-CELL/B-CELL COOPERATION IN HUMORAL IMMUNITY......105 CHAPTER 14 CELL SURFACE MARKERS OF T-CELLS, B-CELLS AND MACROPHAGES...............................................................111
    [Show full text]
  • 1. Introduction to Immunology Professor Charles Bangham ([email protected])
    MCD Immunology Alexandra Burke-Smith 1. Introduction to Immunology Professor Charles Bangham ([email protected]) 1. Explain the importance of immunology for human health. The immune system What happens when it goes wrong? persistent or fatal infections allergy autoimmune disease transplant rejection What is it for? To identify and eliminate harmful “non-self” microorganisms and harmful substances such as toxins, by distinguishing ‘self’ from ‘non-self’ proteins or by identifying ‘danger’ signals (e.g. from inflammation) The immune system has to strike a balance between clearing the pathogen and causing accidental damage to the host (immunopathology). Basic Principles The innate immune system works rapidly (within minutes) and has broad specificity The adaptive immune system takes longer (days) and has exisite specificity Generation Times and Evolution Bacteria- minutes Viruses- hours Host- years The pathogen replicates and hence evolves millions of times faster than the host, therefore the host relies on a flexible and rapid immune response Out most polymorphic (variable) genes, such as HLA and KIR, are those that control the immune system, and these have been selected for by infectious diseases 2. Outline the basic principles of immune responses and the timescales in which they occur. IFN: Interferon (innate immunity) NK: Natural Killer cells (innate immunity) CTL: Cytotoxic T lymphocytes (acquired immunity) 1 MCD Immunology Alexandra Burke-Smith Innate Immunity Acquired immunity Depends of pre-formed cells and molecules Depends on clonal selection, i.e. growth of T/B cells, release of antibodies selected for antigen specifity Fast (starts in mins/hrs) Slow (starts in days) Limited specifity- pathogen associated, i.e.
    [Show full text]
  • Which Is Directly Mediated by Fumigatus Aspergillus Antifungal Activity Against Human NK Cells Display Importa
    Human NK Cells Display Important Antifungal Activity against Aspergillus fumigatus , Which Is Directly Mediated by IFN- γ Release This information is current as of September 28, 2021. Maria Bouzani, Michael Ok, Allison McCormick, Frank Ebel, Oliver Kurzai, C. Oliver Morton, Hermann Einsele and Juergen Loeffler J Immunol 2011; 187:1369-1376; Prepublished online 22 June 2011; Downloaded from doi: 10.4049/jimmunol.1003593 http://www.jimmunol.org/content/187/3/1369 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2011/06/22/jimmunol.100359 Material 3.DC1 References This article cites 41 articles, 14 of which you can access for free at: http://www.jimmunol.org/content/187/3/1369.full#ref-list-1 Why The JI? Submit online. by guest on September 28, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Human NK Cells Display Important Antifungal Activity against Aspergillus fumigatus, Which Is Directly Mediated by IFN-g Release Maria Bouzani,* Michael Ok,* Allison McCormick,† Frank Ebel,† Oliver Kurzai,‡,x C.
    [Show full text]
  • The Host Defense Peptide Cathelicidin Is Required for NK Cell-Mediated Suppression of Tumor Growth
    The Host Defense Peptide Cathelicidin Is Required for NK Cell-Mediated Suppression of Tumor Growth This information is current as Amanda S. Büchau, Shin Morizane, Janet Trowbridge, of September 27, 2021. Jürgen Schauber, Paul Kotol, Jack D. Bui and Richard L. Gallo J Immunol 2010; 184:369-378; Prepublished online 30 November 2009; doi: 10.4049/jimmunol.0902110 Downloaded from http://www.jimmunol.org/content/184/1/369 References This article cites 68 articles, 24 of which you can access for free at: http://www.jimmunol.org/content/184/1/369.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 27, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2010 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology The Host Defense Peptide Cathelicidin Is Required for NK Cell-Mediated Suppression of Tumor Growth Amanda S. Bu¨chau,*,† Shin Morizane,*,† Janet Trowbridge,*,†,1 Ju¨rgen Schauber,*,†,‡ Paul Kotol,*,† Jack D.
    [Show full text]
  • Cytolytic Effector Functions at the Site of Mycobacterium Tuberculosis Infection
    From Center for Infectious Medicine, Department of Medicine Karolinska Institutet, Stockholm, Sweden LOCAL IMMUNE RESPONSES IN TUBERCULOSIS: CYTOLYTIC EFFECTOR FUNCTIONS AT THE SITE OF MYCOBACTERIUM TUBERCULOSIS INFECTION Sayma Rahman Stockholm 2013 All previously published papers were reproduced with permission from the publisher. Cover figure provided by: Dr. Susanna Brighenti Published by Karolinska Institutet. ©Sayma Rahman, 2013 ISBN 978-91-7549-062-5 MY FATHER MY LIFETIME HERO "But I have promises to keep And miles to go before I sleep…….." -Robert Lee Frost ABSTRACT Despite recent advances in tuberculosis (TB) research, shortage of knowledge still exists that limits the understanding of host-pathogen interactions in human TB. Cell-mediated immunity has been shown to confer protection in TB, although the relative importance of cytolytic T cells (CTLs) expressing granule-associated effector molecules perforin and granulysin is debated. A typical hallmark of TB is granuloma formation, which includes organized collections of immune cells that form around Mycobacterium tuberculosis (Mtb)- infected macrophages to contain Mtb infection in the tissue. This thesis aimed to increase insights to the immunopathogenesis involved in the progression of clinical TB, with an emphasis to explore antimicrobial effector cell responses at the local site of Mtb infection. A technological platform including quantitative PCR and in situ computerized image analysis was established to enable assessment of local immune responses in tissues collected from lung or lymph nodes of patients with active pulmonary TB or extrapulmonary TB. The results from this thesis revealed enhanced inflammation and granuloma formation in Mtb-infected organs from patients with active TB disease. CD68+ macrophages expressing the Mtb-specific antigen MPT64 were abundantly present inside the granulomas, which suggest that the granuloma is the main site of bacterial persistence.
    [Show full text]
  • Human Antimicrobial Peptides and Proteins
    Pharmaceuticals 2014, 7, 545-594; doi:10.3390/ph7050545 OPEN ACCESS pharmaceuticals ISSN 1424-8247 www.mdpi.com/journal/pharmaceuticals Review Human Antimicrobial Peptides and Proteins Guangshun Wang Department of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, 986495 Nebraska Medical Center, Omaha, NE 68198-6495, USA; E-Mail: [email protected]; Tel.: +402-559-4176; Fax: +402-559-4077. Received: 17 January 2014; in revised form: 15 April 2014 / Accepted: 29 April 2014 / Published: 13 May 2014 Abstract: As the key components of innate immunity, human host defense antimicrobial peptides and proteins (AMPs) play a critical role in warding off invading microbial pathogens. In addition, AMPs can possess other biological functions such as apoptosis, wound healing, and immune modulation. This article provides an overview on the identification, activity, 3D structure, and mechanism of action of human AMPs selected from the antimicrobial peptide database. Over 100 such peptides have been identified from a variety of tissues and epithelial surfaces, including skin, eyes, ears, mouths, gut, immune, nervous and urinary systems. These peptides vary from 10 to 150 amino acids with a net charge between −3 and +20 and a hydrophobic content below 60%. The sequence diversity enables human AMPs to adopt various 3D structures and to attack pathogens by different mechanisms. While α-defensin HD-6 can self-assemble on the bacterial surface into nanonets to entangle bacteria, both HNP-1 and β-defensin hBD-3 are able to block cell wall biosynthesis by binding to lipid II. Lysozyme is well-characterized to cleave bacterial cell wall polysaccharides but can also kill bacteria by a non-catalytic mechanism.
    [Show full text]
  • Perforin-2 Is Essential for Intracellular Defense of Parenchymal Cells And
    RESEARCH ARTICLE elifesciences.org Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteria Ryan M McCormack1, Lesley R de Armas1, Motoaki Shiratsuchi1, Desiree G Fiorentino1, Melissa L Olsson1, Mathias G Lichtenheld1, Alejo Morales1, Kirill Lyapichev1, Louis E Gonzalez1, Natasa Strbo1, Neelima Sukumar2, Olivera Stojadinovic3, Gregory V Plano1, George P Munson1, Marjana Tomic- Canic3, Robert S Kirsner3, David G Russell2, Eckhard R Podack1* 1Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States; 2Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, United States; 3Wound Healing and Regenerative Medicine Research Program, Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, United States Abstract Perforin-2 (MPEG1) is a pore-forming, antibacterial protein with broad-spectrum activity. Perforin-2 is expressed constitutively in phagocytes and inducibly in parenchymal, tissue-forming cells. In vitro, Perforin-2 prevents the intracellular replication and proliferation of bacterial pathogens in these cells. Perforin-2 knockout mice are unable to control the systemic dissemination of methicillin-resistant Staphylococcus aureus (MRSA) or Salmonella typhimurium and perish shortly after epicutaneous or orogastric infection respectively. In contrast, Perforin-2-sufficient littermates clear the infection. Perforin-2 is a transmembrane protein of cytosolic vesicles -derived from multiple organelles- that translocate to and fuse with bacterium containing vesicles. Subsequently, Perforin-2 polymerizes and forms large clusters of 100 A˚ pores in the bacterial surface with Perforin-2 cleavage products present in bacteria. Perforin-2 is also required for the bactericidal activity of reactive oxygen and nitrogen species and hydrolytic enzymes.
    [Show full text]
  • Granulysin: Killer Lymphocyte Safeguard Against Microbes
    Available online at www.sciencedirect.com ScienceDirect Granulysin: killer lymphocyte safeguard against microbes 1 2 Farokh Dotiwala and Judy Lieberman Primary T cell immunodeficiency and HIV-infected patients are of infected target cells, such as perturbations of major plagued by non-viral infections caused by bacteria, fungi, and histocompatibility protein expression or molecular signs parasites, suggesting an important and underappreciated role of cellular stress, as part of innate immunity. Most killer for T lymphocytes in controlling microbes. Here, we review T cells, as part of the adaptive immune response, only recent studies showing that killer lymphocytes use the expand and become cytotoxic about a week after they first antimicrobial cytotoxic granule pore-forming peptide encounter target cells. However, innate-like killer T cells granulysin, induced by microbial exposure, to permeabilize (gd T cells, NK T cells, mucosal associated invariant cholesterol-poor microbial membranes and deliver death- T (MAIT) cells) that have restricted T cell receptors that inducing granzymes into these pathogens. Granulysin and recognize common features of infected cells, including granzymes cause microptosis, programmed cell death in pathogenic lipids and microbial metabolites, are often microbes, by inducing reactive oxygen species and destroying localized at barrier surfaces where infection enters the microbial antioxidant defenses and disrupting biosynthetic and body. These killer cells may have been activated by other central metabolism pathways
    [Show full text]
  • Fas Ligand, Death Gene
    Cell Death and Differentiation (1999) 6, 1174 ± 1181 ã 1999 Stockton Press All rights reserved 13509047/99 $15.00 http://www.stockton-press.co.uk/cdd Review Fas ligand, death gene MJ Pinkoski*,1 and DR Green*,1 or actinomycin D. Rather than protecting against cell death, both of these agents induced significant death in HL-60 cells, 1 Division of Cellular Immunology, La Jolla Institute for Allergy and thus demonstrating that not all apoptosis was dependent on Immunology, 10355 Science Center Drive, San Diego, California, CA 92121, transcription and translation. In fact, this provided an inkling USA of the complexity of programmed cell death that would soon * Corresponding authors: MJ Pinkoski and DR Green, Division of Cellular become evident. However, the fact remained that in some Immunology, La Jolla Institute for Allergy and Immunology, 10355 Science Center Drive, San Diego, California, CA 92121, USA. Tel: (858) 558-3500; cases, transcription is required for apoptosis to occur and it is Fax: (858) 558-3525; E-mail: [email protected]; [email protected] now pretty much agreed that the requirement for novel RNA and protein synthesis in apoptosis is dependent on the cell type and the apoptotic stimulus. In those cases when Received 2.8.99; revised 1.10.99; accepted 5.10.99 apoptosis is dependent on transcription, the genes that Edited by L Fesus must be transcribed have been termed `death genes'. So- called death genes are those that are not transcriptionally active unless there is some sort of death stimulus. Without Abstract proper activation of the appropriate death gene(s), the The concept of death genes goes back to the early days of ultimate goal of cell death cannot be achieved in some programmed cell death, when a researcher's model system settings.
    [Show full text]